Tirzepatide is a novel synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual incretin mechanism distinguishes tirzepatide from single-receptor GLP-1 agonists, making it a subject of significant interest in metabolic research.
In preclinical research models, tirzepatide has been studied for its capacity to modulate insulin secretion, reduce glucagon release, slow gastric emptying, and influence appetite-regulating pathways. The concurrent activation of both GIP and GLP-1 receptors is being investigated for its synergistic effects on glucose homeostasis, adipose tissue metabolism, and body composition.
This 60mg research quantity is suited to extended studies or multi-subject experimental protocols requiring a higher peptide volume. Each batch is independently tested to confirm identity, purity, and concentration.
Storage: Store at -20°C upon receipt. Protect from light and moisture. Once reconstituted, store at 4°C and use within 30 days.
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.5 g/mol
Purity
>98%
CAS Number
2023788-19-2
Form
Lyophilised Powder
Research Applications
Metabolic disorder research, Obesity and adiposity studies, Glucose homeostasis investigation, Incretin receptor pharmacology, Insulin secretion modelling, Appetite regulation research
For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.
Reviews
There are no reviews yet.